Privacy settings

Utilizziamo cookies tecnici, necessari per il corretto funzionamento del sito, cookies statistici e cookies di marketing (inclusi cookies di terze parti), al fine di mostrarti offerte e pubblicità basate sui tuoi gusti e preferenze. Per maggiori informazioni puoi consultare la nostra Privacy Policy. I cookies statistici e i cookies di marketing (inclusi cookies di terze parti) sono utilizzati esclusivamente con il tuo consenso. Cliccando “Seleziona tutto e acconsenti” consenti il trattamento dei cookies statistici e di marketing (inclusi cookies di terze parti).

Per personalizzare le tue impostazioni privacy, seleziona le tue preferenze tra le caselle qui sotto e clicca “Applica la selezione”. Ti ricordiamo per puoi modificare le tue impostazioni privacy in qualsiasi momento e disattivare i cookies, seguendo le istruzioni riportate nella Privacy Policy.

Show preferences Select all and accept
IMA is loading

Webinars, speeches and presentations

The increasing interest of the pharmaceutical industry in Continuous Manufacturing aims at achieving total quality through a flexible and sustainable production. At IMA, we believe that our commitment can support the change to Continuous Manufacturing.

IMA's way from batch to continuous

Guia Bertuzzi is Product Manager at IMA Active division since 2005. She has been working in mixing, granulation and powders handling systems for more than 20 years. She is expert in pharmaceutical engineering and process for Active Pharmaceutical Ingredients and Oral Solid Dosage forms.

castPlay now
play_circle_outline

From our event Can't stop the future

keyboard_arrow_left keyboard_arrow_right
play_circle_outline

Control strategies for Continuous Manufacturing

Alan Johnston is Senior Life Sciences Consultant at Emerson’s Global consultancy team. He has spent a majority of his career in the Life Sciences industry with a broad range of technical and business experience across production, automation and digitalization including Primary, Secondary and Vaccine manufacture. He has previously held senior technical roles at Siemens, Novartis Vaccines and GSK.

play_circle_outline

How to implement and validate Continuous Manufacturing of direct compression tablets: challenges and opportunities

Frank Streil is Director Technical and Scientific Affairs at Teva/RATIOPHARM. His main interests and experience are in the field of process development and validation as well as in new technologies, PAT and Continuous Manufacturing.

play_circle_outline

Making the switch from batch to Continuous Manufacturing: an industrial perspective

Giustino Di Pretoro is Associate Director at Janssen Pharmaceutica, a Johnson & Johnson Company. He is a subject matter expert and drug product development lead for Continuous Manufacturing, and coordinator for a series of academic collaborations within the field of continuous.

play_circle_outline

Dynamic process models for continuous encapsulation processes

Keirnan LaMarche is Senior Principal Scientist at Patheon. He is an expert in solid dosage form design, continuous manufacturing, and he received his PhD in chemical Engineering from Rutgers University in 2008. He gained 10 years of experience in solid dosage form development at Bristol-Myers Squibb.

play_circle_outline

Global regulatory implementation on Continuous Manufacturing

Moheb M. Nasr managed the CDER Pharmaceutical Analysis Program at the US FDA for four years and had the lead of the CDER/FDA CMC Regulatory Program for more than eight years. He also worked for GSK as VP Global CMC Strategy. In 2018 he started his own consultancy business.

From our Webinar Series

keyboard_arrow_left keyboard_arrow_right
play_circle_outline

Prexima and Croma, integrated technologies for Continuous Manufacturing

How Continuous Manufacturing can improve the quality of pharmaceuticals via fully integrated technologies.

play_circle_outline

The role of integration and new technologies in Continuous Manufacturing

How drug quality can be monitored and improved via fully automated and Integrated Continuous Manufacturing (ICM).

play_circle_outline

Integrated Continuous Manufacturing (ICM) of medicines

How drug quality can be monitored and improved via fully automated and Integrated Continuous Manufacturing (ICM).

play_circle_outline

IMA’s way from batch to continuous

How Continuous Manufacturing can improve the quality of pharmaceuticals in terms of potency, effectiveness and safety. 

Hello!
I’m ODY, do you feel like talking about CROMA?
close
IMA is loading
arrow_back
Chatbot info
ODY is a pilot project that uses artificial intelligence and machine learning to facilitate online interaction between IMA and its website users. ODY is continuously learning and expanding its knowledge base over time, interaction after interaction. For further information, it is always possible to ask ODY to get in touch with a specialist from IMA staff.
arrow_forward close
close